AZRX Research and Charts

AZRX - AzurRx BioPharma Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2019-11-11 (Delayed quote data 2025-05-01)

Last 0.35	Change ⇑ +0.01 (+0.00%)	Volume 20,159
	Open 0.33	High 0.35	Low 0.33

8EMA (Daily) 0.36	40EMA (Daily) 0.43	50EMA (Daily) 0.45	STO (Daily) 21.412	MACD Hist (Daily) -0.001
8EMA (Weekly) 0.423	40EMA (Weekly) 0.77	50EMA (Weekly) 0.90	STO (Weekly) 9.495	MACD Hist (Weekly) 0.026


Company Profile
AzurRx BioPharma Inc is a development stage biopharmaceutical company. The company is focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome-related conditions. Its lead product candidate is MS1819, a yeast-derived recombinant lipase for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP).

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.